Entero Therapeutics Inc (ENTO)
0.4533
+0.04
(+9.23%)
USD |
NASDAQ |
Nov 22, 16:00
0.4433
-0.01
(-2.21%)
After-Hours: 20:00
Entero Therapeutics Enterprise Value: 63.47M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 63.47M |
| November 21, 2024 | 63.29M |
| November 20, 2024 | 63.22M |
| November 19, 2024 | 63.25M |
| November 18, 2024 | 63.41M |
| November 15, 2024 | 63.64M |
| November 14, 2024 | 63.79M |
| November 13, 2024 | 64.31M |
| November 12, 2024 | 64.26M |
| November 11, 2024 | 64.34M |
| November 08, 2024 | 64.59M |
| November 07, 2024 | 64.45M |
| November 06, 2024 | 64.55M |
| November 05, 2024 | 64.70M |
| November 04, 2024 | 64.52M |
| November 01, 2024 | 64.59M |
| October 31, 2024 | 64.36M |
| October 30, 2024 | 64.21M |
| October 29, 2024 | 64.17M |
| October 28, 2024 | 64.07M |
| October 25, 2024 | 64.31M |
| October 24, 2024 | 64.57M |
| October 23, 2024 | 64.19M |
| October 22, 2024 | 64.25M |
| October 21, 2024 | 64.55M |
| Date | Value |
|---|---|
| October 18, 2024 | 64.83M |
| October 17, 2024 | 64.77M |
| October 16, 2024 | 63.98M |
| October 15, 2024 | 63.45M |
| October 14, 2024 | 63.47M |
| October 11, 2024 | 63.55M |
| October 10, 2024 | 63.22M |
| October 09, 2024 | 63.31M |
| October 08, 2024 | 63.30M |
| October 07, 2024 | 63.78M |
| October 04, 2024 | 64.16M |
| October 03, 2024 | 62.97M |
| October 02, 2024 | 62.86M |
| October 01, 2024 | 62.83M |
| September 30, 2024 | 62.95M |
| September 27, 2024 | 62.31M |
| September 26, 2024 | 62.33M |
| September 25, 2024 | 62.25M |
| September 24, 2024 | 62.22M |
| September 23, 2024 | 62.21M |
| September 20, 2024 | 62.27M |
| September 19, 2024 | 62.30M |
| September 18, 2024 | 62.30M |
| September 17, 2024 | 62.34M |
| September 16, 2024 | 62.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9703M
Minimum
Dec 18 2023
114.44M
Maximum
Mar 16 2021
25.10M
Average
14.48M
Median
Enterprise Value Benchmarks
| Pulmatrix Inc | 11.57M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.581M |
| Total Expenses (Quarterly) | 1.893M |
| EPS Diluted (Quarterly) | -0.59 |
| Earnings Yield | -1.49K% |